Weekly Review

19 Nov    Uncategorized
Nov 19

Weekly Review

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 21 November 2020,
Expect consolidation in Indian equities in the near term; rising COVID-19 cases post festive season can play spoilsport for sometime post stellar run….Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 24 October 2020,
Investors have become stock specific amidst largecaps turning expensive; all eyes on ongoing Q2FY21 earnings season, festive sales, COVID-19 related developments and US Presidential elections….Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 17 October 2020,
Bears and Bulls fight it out ahead of festive season amidst weak global cues; correction healthy for investors..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 27 September 2020,
Bears were in charge on weak global cues and rising COVID-19 cases; correction healthy for investors……..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 19 September 2020,
Buoyancy in smallcaps and midcaps continue; escalating COVID-19 cases is extremely worrisome……Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 05 September 2020,
Valuations have turned expensive after a significant rally in the last five months; great deal of maturity required in current market scenario….Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 29 August 2020,
Investors not connected with ground realities; caution warranted as Indian equities running ahead of fundamentals on FPIs liquidity..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 01 August 2020,
IT and Healthcare stocks outperform in July’s 2020 rally; correction in Indian equities would provide margin of safety for fresh entry..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 18 July 2020,
Profit booking and cooling off in Indian equities would be healthy for investors; wait for correction for fresh entry.. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 04 July 2020,
Buoyancy continues in Indian equities; advise not to get carried away by rally led by liquidity.. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 20 June 2020,
Indian equities remain upbeat; investors entered at lower levels should book profits.. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 13 June 2020,
Correction expected to continue as on ground situation bleak; investors should book profits that have entered at lower levels.. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 06 June 2020,
Robust rally witnessed on relaxations in Lockdown 5.0 and positive global cues; suggest investors to be cautions as the rally is owning to change in sentiments and not on economic recovery.. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 30 May 2020,
Recent rally may fizzle out soon on poor ground situation; some more stimulus and relaxations expected… Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 16 May 2020,
Stimulus package fails to impress street participants; recommend investors to select quality companies for their basket of equities.. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 09 May 2020,
India Inc. needs a major fiscal package soon to withstand ongoing COVID-19 crisis; gradually build portfolio in qualiy companies for long term..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 02 May 2020,
Expect a steep fall as the whopping rally in April 2020 was beyond logic major fiscal package required to undo damage caused by COVID-19 crisis..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 25 April 2020,
The delay in announcing a major package is baffling; all eyes are on North Block..Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 18 April 2020,
RBI’S booster package helps domestic bourses end in postive terrain; unprecedented times require unprecedented measures from the Government….Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 11 April 2020,
Robust rally witnessed in Benchmark indices led by upstick in Pharma, FMCG and Auto stocks; all eyes on crude oil price movement and COVID-19 developments….. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 04 April 2020,
COVID-19 takes a toll on Indian and global developments….. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 21 March 2020,
Worst weekly performance witnessed since 2008; all eyes on COVID-19 developments and crude oil price…….. Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 29 February 2020,
Menace of Coronavirus creates blood bath across global markets; all eyes on key developments related to Coronavirus, movement of crude oil price and rupee against the US$…… Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 15 February 2020,
Stock specific action to be witnessed; all eyes on telecom blues…… Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column on 18 January, 2020
Rally to continue in midcaps and smallcaps space; all eyes on Q3FY20 earnings season and Union Budget 2020-21…… Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column as on 04 January, 2020
Big rally expected in midcaps and smallcaps space; global events remain an over hang……Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column as on December 21, 2019
Sensex and Nifty hit record highs; all eyes on global cues…… Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column as on December 07, 2019
Domestic bourses consolidate; global cues will drive market direction…… Download

Dr. Ashok Ajmera (FCA), CMD & CEO

Dr. Ashok Ajmera’s column as on November 30, 2019
Q2FY20 GDP data lowest in 6 years – FPIs continue their buying spree; all eyes would be on Monetary policy……Download

more details for weekly review

Leave a Reply

Your email address will not be published. Required fields are marked *